sensitivity in HIV-lipodystrophy Depot-specific regulation of glucose uptake and insulin

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Adipocyte Apoptosis in Lipoatrophy Improves Within 48 Weeks of Switching Patient Therapy From Stavudine to Abacavir or Zidovudine

  2005cited by this paper
• In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

  2005cited by this paper
• The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro

  2004cited by this paper
• Acquired and inherited lipodystrophies.

  2004cited by this paper
• Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.

  2004cited by this paper
• Splanchnic lipolysis in human obesity.

  2004cited by this paper
• F-18-Fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients

  2004cited by this paper
• Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices.

  2003cited by this paper
• Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.

  2003cited by this paper
• Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.

  2003cited by this paper
• Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.

  2003cited by this paper
• Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.

  2003cited by this paper
• Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.

  2003cited by this paper
• Altered Fat Differentiation and Adipocytokine Expression are Inter-Related and Linked to Morphological Changes and Insulin Resistance in HIV-1-Infected Lipodystrophic Patients

  2003cited by this paper
• Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.

  2003cited by this paper
• Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy.

  2002cited by this paper
• Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

  2002cited by this paper
• Mitochondrial Proliferation, Dna Depletion and Adipocyte Differentiation in Subcutaneous Adipose Tissue of HIV-Positive Haart Recipients

  2002cited by this paper
• Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.

  2002cited by this paper
• Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations

  2002cited by this paper
• Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men.

  2002cited by this paper
• Adiponectin and Leptin Levels in HIV‐Infected Subjects With Insulin Resistance and Body Fat Redistribution

  2002cited by this paper
• Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

  2002cited by this paper
• Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy

  2002cited by this paper
• Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy.

  2002cited by this paper
• Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

  2001cited by this paper
• The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle.

  2001cited by this paper
• Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

  2001cited by this paper
• Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus.

  2001cited by this paper
• Metabolic effects of indinavir in healthy HIV-seronegative men

  2001cited by this paper
• Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study

  2000cited by this paper
• Anatomy of SUV

  2000cited by this paper
• Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV Lipodystrophy

  2000cited by this paper
• Insulin sensitivity and its measurement: structural commonalities among the methods.

  2000cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy.

  1999cited by this paper
• The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.

  1996cited by this paper
• Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*)

  1995cited by this paper
• Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

  1994cited by this paper
• Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells.

  1993cited by this paper
• Quantitation of positional isomers of deuterium-labeled glucose by gas chromatography/mass spectrometry.

  1992cited by this paper
• Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

  1992cited by this paper
• Use of a variable tracer infusion method to determine glucose turnover in humans.

  1990cited by this paper
• Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.

  1989cited by this paper
• Determination of steady state and nonsteady-state glycerol kinetics in humans using deuterium-labeled tracer.

  1987cited by this paper
• Estimation of Endogenous Glucose Production During Hyperinsulinemic-Euglycemic Glucose Clamps: Comparison of Unlabeled and Labeled Exogenous Glucose Infusates

  1987cited by this paper
• Assessment of abdominal fat content by computed tomography.

  1982cited by this paper
• Glucose metabolism in man: responses to intravenous glucose infusion.

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper

• No citing papers are available for this paper.